Fibryga
- Product NDC
- 68982-347
- Requested package NDC
- 68982-347-01
- 11-digit product format
- 689820347
- Labeler code
- 68982
- Product ID
- 68982-347_6992507e-97be-76ce-a0dc-902d94433f9b
- Type
- PLASMA DERIVATIVE
- Nonproprietary name
- Fibrinogen (Human)
- Dosage form
- KIT
- Route
- INTRAVENOUS
- Labeler
- Octapharma USA Inc
- Application
- BLA125612
- Marketing category
- BLA
- Marketing start
- 2017-10-16
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Fibryga
- Listing expiration
- 2027-12-31
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 007a93f4-d84b-1fa9-51ed-32f6140bf423 | Available on FDA.report |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68982-347-01 | Fibryga | 1 in 1 CARTON | KIT | 1 | 13 | |
| 68982-348-01 | Fibryga | 50 mL in 1 BOTTLE, GLASS | POWDER, FOR SOLUTION | 50 mL | 20 mg in 1mL | 13 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68982-347-01 | EA - Each | 68982-347 | 6d12a71c-3a7c-4388-b7e9-699a0ed0c47a | 1 | 2018-01-12 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fibryga | FIBRINOGEN (HUMAN) | Octapharma USA Inc | e3422d2a-2cb6-6f49-0be7-cb960b3d5bd5 | 2025-08-05 | Warnings, Adverse reactions | BLA125612 |
| Fibryga | FIBRINOGEN (HUMAN) | Octapharma USA Inc | 007a93f4-d84b-1fa9-51ed-32f6140bf423 | 2024-07-31 | Warnings, Adverse reactions | BLA125612 68982-347-01 68982-347 68982034701 |
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125612 | Fibryga | Fibrinogen (Human) | 351(a) | Rx | 2026-10-01 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 831506 | fibrinogen, human 1 MG Injection | PSN | 007a93f4-d84b-1fa9-51ed-32f6140bf423 | 13 |
| 1947382 | fibryga 1 MG Injection | PSN | 007a93f4-d84b-1fa9-51ed-32f6140bf423 | 13 |
| 1947382 | fibrinogen, human 1 MG Injection [Fibryga] | SBD | 007a93f4-d84b-1fa9-51ed-32f6140bf423 | 13 |
| 831506 | fibrinogen, human 1 MG Injection | SCD | 007a93f4-d84b-1fa9-51ed-32f6140bf423 | 13 |
| 831506 | fibrinogen concentrate (human) 1 MG Injection | SY | 007a93f4-d84b-1fa9-51ed-32f6140bf423 | 13 |
| 831506 | fibrinogen, human 1 MG Injection | SY | 007a93f4-d84b-1fa9-51ed-32f6140bf423 | 13 |
| 1947382 | Fibryga 1 MG Injection | SY | 007a93f4-d84b-1fa9-51ed-32f6140bf423 | 13 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68982-347-01 | 68982034701 | 1 KIT in 1 CARTON (68982-347-01) * 50 mL in 1 BOTTLE, GLASS (68982-348-01) | 1 kit | 2017-10-16 | 0000-00-00 | No | No | Current |